glp 1 drugs and parkinson's disease Are we measuring the wrong primary outcome for GLP-1 for Parkinson's? Spoiler alert: the pooled data suggests we should pivot away from a motor outcome. Should we think cognitive, autonomic, sleep The expanding role of GLP-1

Further, the high interassay variability of this test 70 would suggest that mild cases may be missed as shown in one study 24 and that the test may not be appropriate for serial monitoring

The antioxidant activity of polysaccharides derived from marine organisms: An overview

Understanding the role of acetaminophen during pregnancy, discussing concerns with healthcare providers, and making informed decisions are crucial steps for parents to navigate the complex topic of the link between Tylenol and autism

310 The underlying mechanisms of various dietary interventions mainly include altering neurotransmitters, remodeling, interfering with brain energy metabolism and mitochondrial function, and altering inflammation and oxidative stress